Novartis Advertising Cited By FDA For Fifth Time In Less Than A Year
This article was originally published in The Pink Sheet Daily
Executive Summary
CBER's Advertising and Promotional Labeling Branch says that Novartis improperly expanded the age range for its Fluvirin influenza vaccine.